2021 ICD-10-CM Code M60.061
Infective myositis, right lower leg
Valid for Submission
M60.061 is a billable diagnosis code used to specify a medical diagnosis of infective myositis, right lower leg. The code M60.061 is valid during the fiscal year 2021 from October 01, 2020 through September 30, 2021 for the submission of HIPAA-covered transactions.
| ICD-10: | M60.061 |
| Short Description: | Infective myositis, right lower leg |
| Long Description: | Infective myositis, right lower leg |
Code Classification
Diagnostic Related Groups - MS-DRG Mapping
The ICD-10 code M60.061 is grouped in the following groups for version MS-DRG V38.0 What are Diagnostic Related Groups?
The Diagnostic Related Groups (DRGs) are a patient classification scheme which provides a means of relating the type of patients a hospital treats. The DRGs divides all possible principal diagnoses into mutually exclusive principal diagnosis areas referred to as Major Diagnostic Categories (MDC). applicable from 10/01/2020 through 09/30/2021.
Convert M60.061 to ICD-9 Code
The General Equivalency Mapping (GEM) crosswalk indicates an approximate mapping between the ICD-10 code M60.061 its ICD-9 equivalent. The approximate mapping means there is not an exact match between the ICD-10 code and the ICD-9 code and the mapped code is not a precise representation of the original code.
- 728.0 - Infective myositis (Approximate Flag)
Information for Patients
Myositis
Myositis means inflammation of the muscles that you use to move your body. An injury, infection, or autoimmune disease can cause it. Two specific kinds are polymyositis and dermatomyositis. Polymyositis causes muscle weakness, usually in the muscles closest to the trunk of your body. Dermatomyositis causes muscle weakness, plus a skin rash.
Other symptoms of myositis may include
- Fatigue after walking or standing
- Tripping or falling
- Trouble swallowing or breathing
Doctors may use a physical exam, lab tests, imaging tests and a muscle biopsy to diagnose myositis. There is no cure for these diseases, but you can treat the symptoms. Polymyositis and dermatomyositis are first treated with high doses of a corticosteroid. Other options include medications, physical therapy, exercise, heat therapy, assistive devices, and rest.
NIH: National Institute of Neurological Disorders and Stroke
- Creatine phosphokinase test (Medical Encyclopedia)
- Dermatomyositis (Medical Encyclopedia)
- Polymyositis - adult (Medical Encyclopedia)
[Learn More]
Code History
- FY 2021 - No Change, effective from 10/1/2020 through 9/30/2021
- FY 2020 - No Change, effective from 10/1/2019 through 9/30/2020
- FY 2019 - No Change, effective from 10/1/2018 through 9/30/2019
- FY 2018 - No Change, effective from 10/1/2017 through 9/30/2018
- FY 2017 - No Change, effective from 10/1/2016 through 9/30/2017
- FY 2016 - New Code, effective from 10/1/2015 through 9/30/2016 (First year ICD-10-CM implemented into the HIPAA code set)